Form 4: Globus Medical Director Stephen Zarrilli Acquires 15,000 Stock Options
SEC Form 4 Filing
Director Stephen T Zarrilli acquired 15,000 stock options in Globus Medical Inc. on January 23, 2025, according to a Form 4 filing.
Summary
- Stephen T Zarrilli, a director of Globus Medical Inc., filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on January 23, 2025.
- Zarrilli acquired 15,000 stock options (Right to Buy Class A Common Stock) with an exercise price of $92.42.
- These options will vest on January 1, 2026, and expire on January 23, 2035.
- Following the transaction, Zarrilli directly owns 15,000 derivative securities.
- The filing was signed by Kelly G. Huller, Attorney-in-Fact, on March 28, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating a standard compensation practice. The acquisition of stock options by a director is generally viewed as a positive, but it's not a major event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation in the medical device industry.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the medical device industry, used to align management's interests with those of shareholders.
- Companies like Stryker (SYK) and Medtronic (MDT) also utilize stock options as part of their executive compensation plans.
- The vesting schedule and exercise price are typical for such grants.
Stakeholder Impact
- The acquisition of stock options by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/23/2025 | Date of stock option grant. |
| 01/01/2026 | Vesting date of the stock options. |
| 01/23/2035 | Expiration date of the stock options. |
| 03/28/2025 | Date of Form 4 filing. |
Keywords
Form 4, Globus Medical, Stock Options, Director, Acquisition, GMED, Zarrilli
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.